Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples